ASA in the News
Reintroduced CARERS Act Would Protect States' Rights, Medical Marijuana Patients - Americans for Safe Access
By Thomas Mitchell for Westword
Days after a letter from Attorney General Jeff Sessions surfaced, asking congressional leaders to revoke federal protections for medical marijuana, senators have introduced a bill that would protect medical marijuana patients in states where it's legal while also removing cannabidiol (CBD) from the Controlled Substances Act and expanding research on marijuana.
By the Associated Press for WTOP
No other U.S. state is taking the research-before-legislation route because they realize it is futile, said Jahan Marcu of Americans for Safe Access, a national medical cannabis advocacy group.
“It’s never been shown to work in the past, so we are not confident that it’s going to serve the needs of patients,” he said of the process.
By Maui Now
Hawaiʻi Department of Health has received a “B” and was ranked the fifth highest in the nation for its medical marijuana program, based on a recent report card of new, regulated medical marijuana distribution programs issued by Americans for Safe Access.
The national organization’s mission is to reduce barriers to medical cannabis by creating policies to improve access for patients and researchers, using legislation, education, litigation, research and other means.
According to the report card, “Hawaiʻi is on track to become one of the best programs in the country if they continue with their timely implementation.”
By Steph Sherer for The Hill
The phrase “no news is good news” should mean an assurance that a situation is not dramatically worsening, and perhaps even improving. For the first 100 days of Trump’s Presidency, the lack of news surrounding medical cannabis has been, for the most part, good news for the status quo. However, this is not a comfort to medical cannabis patients for whom behind the scenes actions could upend, disrupt, or delay access to their medication.
By Francisco Alvarado for Vice
“Whether or not doctors or other health care professionals have any intention of recommending medical cannabis for patient care, they all need to be well educated in this clinical area because their patients will be seeking their expert advice and guidance for this medication,” noted Stephen B. Corn, MD, a specialist in anesthesiology, perioperative and pain medicine at Brigham and Women’s Hospital and Children’s Hospital, both in Boston. Since patients may already be using medical marijuana, clinicians “need to be aware of the physiological effects of cannabis as well as potential drug interactions and side effects,” Dr. Corn added, stressing that expertise in medical cannabis will be necessary for most doctors, pharmacists, nurses and other health care professionals.
For CBS Miami
“When we look at tools to combat the opioid crisis, I think it’s amazing that medical cannabis is a tool we can use. At the heart of all of our challenges is the fact that the federal government sees cannabis as more dangerous than methamphetamines or cocaine.” - Steph Sherer
Themes Emerging from the 2017 Americans for Safe Access Unity Conference - Americans for Safe Access
By Chloe Detrick for Ganjapreneur
“I feel that ASA is only going to continue growing as more and more states begin introducing legalization efforts. We are going to continue to get involved with state governments and assist them in ensuring that people are doing things the right way.” - Beth Collins
By Marcia Coyle for The National Law Journal
A team from Orrick, Herrington & Sutcliffe, representing the medical marijuana advocate Americans for Safe Access, isn’t holding its breath for federal drug enforcement officials to erase their alleged misstatements about the health risks of cannabis.
The U.S. Drug Enforcement Administration has not responded to a petition from Americans for Safe Access that sought to correct allegedly false and misleading information from the DEA’s website. Orrick filed the petition in late last year.
The next step? A possible lawsuit, said Orrick’s Vickie Feeman, a partner in the firm’s Silicon Valley office who is leading the pro bono effort for the pro-marijuana advocate.
Larger-scale research, better regulation needed
By Ryan Basen for Medpage Today
WASHINGTON -- Medicinal cannabis industry officials and scholars here touted potential breakthroughs to treat health problems and questioned why cannabidiol (CBD) is not mandatory for athletes to address traumatic brain injury (TBI). Others, meanwhile, cautioned the field needs much more research and regulation.
"The whole concept of cannabis as medicine is very new," Stuart Titus, PhD, told MedPage Today during an interview at the Americans for Safe Access (ASA) annual meeting on medical cannabis last week. "Everything is at such a ground-floor state."